How does sublingual immunotherapy work?

Journal of Allergy and Clinical Immunology

Volumn 120, Issue 3, 2007, Pages 533-536

  Frew, Anthony J ^a  

^a BRIGHTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; INTERLEUKIN 10;

BIRCH; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CLINICAL EFFECTIVENESS; EDITORIAL; HUMAN; IMMUNE SYSTEM; IMMUNOTHERAPY; PRIORITY JOURNAL; T LYMPHOCYTE;

ADMINISTRATION, SUBLINGUAL; ALLERGENS; DESENSITIZATION, IMMUNOLOGIC; HUMANS; HYPERSENSITIVITY; RANDOMIZED CONTROLLED TRIALS;

EID: 34548282589     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2007.08.003     Document Type: Editorial

References (32)

1. Wilson D.R., Lima M.T., and Durham S.R. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 60 (2005) 4-12
2. Durham S.R., Yang W.H., Pedersen M.R., Johansen N., and Rak S. Sublingual immunotherapy with once-daily grass tablets: a randomised controlled trial in seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 117 (2006) 802-809
3. Dahl R., Stender A., and Rak S. Specific immunotherapy with SQ-standardised grass allergen tablets in asthmatics with rhinoconjunctivitis. Allergy 61 (2006) 185-190
4. Dahl R., Kapp A., Colombo G., de Monchy J.G., Rak S., Emminger W., et al. Efficacy and safety of sublingual immunotherapy with once daily grass allergen tablets for seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 118 (2006) 434-440
5. Cooke R.A., Barnard J.H., Hebald S., and Stull A. Serological evidence of immunity with coexisting sensitization in a type of human allergy. J Exp Med 62 (1935) 733-750
6. Lambin P., Bouzoumou A., Murreita M., Debbia M., Rouger P., Leynadier F., et al. Purification of human IgG4 subclass with allergen-specific blocking activity. J Immunol Methods 165 (1993) 99-111
7. Satoguina J.S., Weyand E., Larbi J., and Hoerauf A. T-regulatory-1 cells induce IgG4 production by B cells: role of IL-10. J Immunol 174 (2005) 4718-4726
8. Lichtenstein L.M., Ishizaka K., Norman P.S., Sobotka A.K., and Hill B.M. IgE measurements in ragweed hay fever. Relationship to clinical severity and the results of immunotherapy. J. Clin Invest 52 (1973) 472-482
9. Ewan P.W., Deighton J., Wilson A.B., and Lachmann P.J. Venom-specific IgG antibodies in bee and wasp allergy: lack of correlation with protection from stings. Clin Exp Allergy 23 (1993) 647-660
10. Pienkowski M., Norman P.S., and Lichtenstein L.M. Suppression of late-phase reactions by immunotherapy with ragweed extract. J Allergy Clin Immunol 76 (1985) 729-734
11. McHugh S.M., Deighton J., Stewart A.G., Lachman P.J., and Ewan P.W. Bee venom immunotherapy induces a shift in cytokine responses from a Th2 to a Th1 dominant pattern: comparison of rush and conventional immunotherapy. Clin Exp Allergy 25 (1995) 828-838
12. Varney V.A., Hamid Q.A., Gaga M., Ying S., Jacobson M., Frew A.J., et al. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses. J Clin Invest 92 (1993) 644-651
13. Durham S.R., Ying S., Varney V.A., Jacobson M.R., Sudderick R.M., Mackay I.S., et al. Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T-lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing mRNA for interferon-gamma. J Allergy Clin Immunol 97 (1996) 1356-1365
14. Nouri-Aria K.T., Wachholz P.A., Francis J.N., Jacobson M.R., Walker S.M., Wilcock L.K., et al. Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity. J Immunol 172 (2004) 3252-3259
15. Jutel M., Pichler W.J., Skrbic D., Urwyler A., Dahinden C., and Muller U. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-gamma secretion in specific allergen-stimulated T cell cultures. J Immunol 154 (1995) 4187-4194
16. Akdis C.A., Verhagen J., Taylor A., Karamloo F., Karagiannidis C., and Crameri R. Immune responses in healthy and atopic individuals are characterised by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med 199 (2004) 1567-1575
17. Bagnasco M., Mariani G., Passalacqua G., Motta C., Bartolomei M., Falagiani P., et al. Absorption and distribution kinetics of the major Parietaria judaica allergen (Par j 1) administered by noninjectable routes in healthy human beings. J Allergy Clin Immunol 100 (1997) 122-129
18. Allam J.P., Novak N., Fuchs C., Asen S., Berge S., Appel T., et al. Characterization of dendritic cells from human oral mucosa: a new Langerhans' cell type with high constitutive FcεRI expression. J Allergy Clin Immunol 112 (2003) 141-148
19. Pajno G.B., Morabito L., Barberio G., and Parmiani S. Clinical and immunological effects of long-term sublingual immunotherapy in asthmatic children sensitised to mites: a double-blind, placebo-controlled study. Allergy 55 (2000) 842-849
20. Smith H.E., White P.J., Annila I., Poole J., Andre C., and Frew A.J. Randomised controlled trial of high dose sublingual immunotherapy to treat seasonal allergic rhinitis. J Allergy Clin Immunol 114 (2004) 831-837
21. Hawrylowicz C.M., and O'Garra A. Potential role of IL-10-secreting regulatory T cells in allergy and asthma. Nat Rev Immunol 5 (2005) 271-283
22. Savolainen J., Jacobsen L., and Valovirta E. Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PBMC. Allergy 61 (2006) 1184-1190
23. Ciprandi G., Fenoglio D., Cirillo I., Vizzaccaro A., Ferrara A., Tosca M.A., et al. Induction of IL-10 by sublingual immunotherapy for house dust mites: a preliminary report. Ann Allergy Asthma Immunol 95 (2005) 38-44
24. Cosmi L., Santarlasci V., Angeli R., Liotta F., Maggi L., Frosali F., et al. Sublingual immunotherapy with Dermatophagoides monomeric allergoid downregulates allergen-specific IgE and increases both interferon-gamma and IL-10 production. Clin Exp Allergy 36 (2006) 261-272
25. Fanta C., Bohle B., Hirt W., Siemann U., Horak F., Kraft D., et al. Systemic immunological changes induced by administration of grass pollen allergens via the oral mucosa during sublingual immunotherapy. Int Arch Allergy Appl Immunol 120 (1999) 218-224
26. Kinaciyan T., Jahn-Schmid B., Radakovics A., Zwolfer B., Schreiber C., Francis J.N., et al. Successful sublingual immunotherapy with birch pollen has limited effects on concomitant food allergy to apple and the immune response to the Bet v1 homolog Mal d1. J Allergy Clin Immunol 119 (2007) 937-944
27. Cosmi L., Santarlasci V., Angeli R., Liotta F., Maggi L., Frosali F., et al. SLIT with Dermatophagoides monomeric allergoids downregulates allergen-specific IgE and increases both IFN-γ and IL-10 production. Clin Exp Allergy 36 (2006) 261-272
28. Marogna M., Spadolini I., Massolo A., Canonica G.W., and Passalacqua G. Clinical, functional, and immunologic effects of sublingual immunotherapy in birch pollinosis: a 3-year randomized controlled study. J Allergy Clin Immunol 115 (2005) 1184-1188
29. Ippoliti F., De Santis W., Volterrani A., Lenti L., Canitano N., Lucarelli S., et al. Immunomodulation during sublingual therapy in allergic children. Pediatr Allergy Immunol 14 (2003) 216-221
30. Zhu Z., Homer R.J., Wang Z., Chen Q., Geba G.P., Wang J., et al. Pulmonary expression of IL-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities and eotaxin production. J Clin Invest 103 (1999) 779-788
31. Bohle B., Kinaciyan T., Gerstmayr M., Radakovics A., Jahn-Schmid B., and Ebner C. Sublingual immunotherapy induces IL-10-producing T regulatory cells. Allergen-specific T-cell tolerance and immune deviation. J Allergy Clin Immunol 120 (2007) 707-713
32. Jutel M., Akdis M., Budak F., Aebischer-Casaulta C., Wrzyszcz M., Blaser K., et al. Il-10 and TGF-beta co-operate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 33 (2003) 1205-1214